1. Home
  2. IDYA vs SIMO Comparison

IDYA vs SIMO Comparison

Compare IDYA & SIMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDYA
  • SIMO
  • Stock Information
  • Founded
  • IDYA 2015
  • SIMO 1995
  • Country
  • IDYA United States
  • SIMO Hong Kong
  • Employees
  • IDYA N/A
  • SIMO N/A
  • Industry
  • IDYA Biotechnology: Pharmaceutical Preparations
  • SIMO Semiconductors
  • Sector
  • IDYA Health Care
  • SIMO Technology
  • Exchange
  • IDYA Nasdaq
  • SIMO Nasdaq
  • Market Cap
  • IDYA 1.5B
  • SIMO 1.3B
  • IPO Year
  • IDYA 2019
  • SIMO 2005
  • Fundamental
  • Price
  • IDYA $17.42
  • SIMO $53.54
  • Analyst Decision
  • IDYA Strong Buy
  • SIMO Strong Buy
  • Analyst Count
  • IDYA 13
  • SIMO 8
  • Target Price
  • IDYA $53.58
  • SIMO $77.50
  • AVG Volume (30 Days)
  • IDYA 1.4M
  • SIMO 549.6K
  • Earning Date
  • IDYA 05-06-2025
  • SIMO 04-29-2025
  • Dividend Yield
  • IDYA N/A
  • SIMO 3.73%
  • EPS Growth
  • IDYA N/A
  • SIMO 59.19
  • EPS
  • IDYA N/A
  • SIMO 2.80
  • Revenue
  • IDYA $7,000,000.00
  • SIMO $780,733,000.00
  • Revenue This Year
  • IDYA $121.20
  • SIMO $2.80
  • Revenue Next Year
  • IDYA $302.20
  • SIMO $13.32
  • P/E Ratio
  • IDYA N/A
  • SIMO $18.88
  • Revenue Growth
  • IDYA N/A
  • SIMO 10.84
  • 52 Week Low
  • IDYA $13.45
  • SIMO $37.21
  • 52 Week High
  • IDYA $44.42
  • SIMO $85.87
  • Technical
  • Relative Strength Index (RSI)
  • IDYA 43.87
  • SIMO 65.04
  • Support Level
  • IDYA $16.82
  • SIMO $51.31
  • Resistance Level
  • IDYA $21.43
  • SIMO $53.99
  • Average True Range (ATR)
  • IDYA 1.16
  • SIMO 2.04
  • MACD
  • IDYA -0.16
  • SIMO 1.35
  • Stochastic Oscillator
  • IDYA 13.02
  • SIMO 96.90

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is active in the semiconductor industry and focuses on designing, developing, and marketing of controllers for managing NAND flash used in embedded storage applications, such as eMMC embedded memory. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

Share on Social Networks: